Protara Therapeutics, Inc. (Nasdaq:TARA)

Health Care/Life Sciences • Biotechnology

CIK 1359931

Company

Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY.

Address
345 Park Avenue South
3rd Floor
New York, New York 10010

Employees
25

Stock Info

Close
$3.7400

Day Range
3.6300 - 4.4200

52 Week Range
1.0400 - 4.9500

Average volume
74.57K

Short Interest
58.98K (02/15/24)

% of Float Shorted
0.65%

Market Cap
$50.01M

Revenue
N/A

Net Income
-$65.95M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$6.1262

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

President, Chief Executive Officer & Director
Jesse Shefferman MBA

Chairman
Luke M Beshar CPA

Independent Director
Cynthia Smith MBA

Independent Director
Richard S Levy MD

Independent Director
Gregory P Sargen MBA, CPA

Independent Director
Roger J Garceau MD, PhD

Independent Director
Michael E Solomon PhD

Independent Director
Jane E Huang MD

Independent Director
Barry P Flannelly PhD, MBA

SEC filings

Date	Form	Event
17 Dec, 2024	SC 13G
11 Dec, 2024	8-K
11 Dec, 2024	424B5
9 Dec, 2024	424B5
5 Dec, 2024	8-K
18 Nov, 2024	SC 13G
14 Nov, 2024	SC 13G
14 Nov, 2024	SC 13G/A
12 Nov, 2024	10-Q
12 Nov, 2024	8-K
12 Sep, 2024	4
10 Sep, 2024	4
30 Aug, 2024	4
6 Aug, 2024	S-8
6 Aug, 2024	10-Q
6 Aug, 2024	8-K
18 Jul, 2024	4
11 Jul, 2024	4
3 Jul, 2024	4
28 Jun, 2024	4
27 Jun, 2024	4
10 Jun, 2024	4
10 Jun, 2024	4
10 Jun, 2024	4
10 Jun, 2024	4
10 Jun, 2024	8-K
10 Jun, 2024	4
10 Jun, 2024	4
10 Jun, 2024	4
10 Jun, 2024	4
31 May, 2024	4
23 May, 2024	4
17 May, 2024	4
10 May, 2024	4
9 May, 2024	EFFECT
9 May, 2024	424B3
7 May, 2024	UPLOAD
7 May, 2024	CORRESP
2 May, 2024	S-3
2 May, 2024	8-K
2 May, 2024	10-Q
26 Apr, 2024	DEFA14A
26 Apr, 2024	ARS
26 Apr, 2024	DEF 14A
25 Apr, 2024	SC 13G
22 Apr, 2024	SC 13G
9 Apr, 2024	SC 13G
5 Apr, 2024	8-K
18 Mar, 2024	8-K
14 Mar, 2024	S-8
13 Mar, 2024	8-K
13 Mar, 2024	10-K
14 Feb, 2024	SC 13G/A
23 Jan, 2024	4
23 Jan, 2024	4
23 Jan, 2024	4
23 Jan, 2024	4
23 Jan, 2024	4
12 Jan, 2024	4
12 Jan, 2024	4
12 Jan, 2024	4
5 Jan, 2024	4
5 Jan, 2024	4
5 Jan, 2024	4
14 Nov, 2023	EFFECT
9 Nov, 2023	CORRESP
7 Nov, 2023	UPLOAD
3 Nov, 2023	10-Q
3 Nov, 2023	S-3
3 Nov, 2023	8-K
3 Aug, 2023	8-K
3 Aug, 2023	10-Q
18 Jul, 2023	4
5 Jul, 2023	4
27 Jun, 2023	4
8 Jun, 2023	4
8 Jun, 2023	8-K
8 Jun, 2023	4
8 Jun, 2023	4
8 Jun, 2023	4
8 Jun, 2023	4
8 Jun, 2023	4
8 Jun, 2023	4
8 Jun, 2023	4
4 May, 2023	10-Q
4 May, 2023	8-K
2 May, 2023	8-K
28 Apr, 2023	8-K
26 Apr, 2023	DEF 14A
26 Apr, 2023	ARS
26 Apr, 2023	DEFA14A
10 Mar, 2023	8-K
8 Mar, 2023	10-K
8 Mar, 2023	8-K
8 Mar, 2023	S-8
14 Feb, 2023	SC 13G/A
10 Feb, 2023	5
30 Jan, 2023	4
30 Jan, 2023	3
30 Jan, 2023	8-K	CEO Change
20 Jan, 2023	4
20 Jan, 2023	4
20 Jan, 2023	4
20 Jan, 2023	4
11 Jan, 2023	4
11 Jan, 2023	4
11 Jan, 2023	4
5 Jan, 2023	8-K
4 Jan, 2023	4
4 Jan, 2023	4
4 Jan, 2023	4
30 Dec, 2022	4
3 Nov, 2022	8-K
3 Nov, 2022	10-Q
15 Sep, 2022	4
15 Aug, 2022	4
9 Aug, 2022	8-K
9 Aug, 2022	10-Q
19 Jul, 2022	4
19 Jul, 2022	4
19 Jul, 2022	3
18 Jul, 2022	8-K	CEO Change
5 Jul, 2022	4
5 Jul, 2022	4
21 Jun, 2022	8-K
9 Jun, 2022	4
9 Jun, 2022	8-K
9 Jun, 2022	4
9 Jun, 2022	4
9 Jun, 2022	4
9 Jun, 2022	4
9 Jun, 2022	4
9 Jun, 2022	4
9 Jun, 2022	4
5 May, 2022	8-K
27 Apr, 2022	DEFA14A
27 Apr, 2022	DEF 14A
15 Apr, 2022	4/A
8 Apr, 2022	4
16 Mar, 2022	4
14 Mar, 2022	4
9 Mar, 2022	8-K
9 Mar, 2022	S-8
9 Mar, 2022	4/A
9 Mar, 2022	10-K
15 Feb, 2022	SC 13G/A
15 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
11 Feb, 2022	SC 13G
11 Feb, 2022	5
31 Jan, 2022	4
12 Jan, 2022	4
12 Jan, 2022	4
12 Jan, 2022	4
12 Jan, 2022	3
10 Jan, 2022	8-K
5 Jan, 2022	4
5 Jan, 2022	4
5 Jan, 2022	4
29 Dec, 2021	4
27 Dec, 2021	4
22 Dec, 2021	4
20 Dec, 2021	4
19 Nov, 2021	4
8 Nov, 2021	4
4 Nov, 2021	8-K
4 Nov, 2021	10-Q
18 Oct, 2021	8-K
12 Oct, 2021	8-K
5 Aug, 2021	10-Q
5 Aug, 2021	8-K
14 Jun, 2021	4
10 Jun, 2021	4
10 Jun, 2021	8-K
10 Jun, 2021	3
10 Jun, 2021	3/A
10 Jun, 2021	4
10 Jun, 2021	4
10 Jun, 2021	4
10 Jun, 2021	4
10 Jun, 2021	4
10 Jun, 2021	4
10 Jun, 2021	4
6 May, 2021	10-Q
27 Apr, 2021	DEFA14A
27 Apr, 2021	DEF 14A
23 Apr, 2021	8-K
20 Apr, 2021	3
20 Apr, 2021	4
19 Apr, 2021	8-K
23 Mar, 2021	SEC STAFF
17 Mar, 2021	8-K
11 Mar, 2021	S-8
11 Mar, 2021	10-K
3 Mar, 2021	8-K
23 Feb, 2021	SEC STAFF
16 Feb, 2021	SC 13G/A
16 Feb, 2021	SC 13G/A
12 Feb, 2021	SC 13G/A
11 Feb, 2021	8-K
2 Feb, 2021	8-K
1 Feb, 2021	4
1 Feb, 2021	3
21 Jan, 2021	4
21 Jan, 2021	4
21 Jan, 2021	4
13 Jan, 2021	4
13 Jan, 2021	4
8 Jan, 2021	SC 13D/A
16 Dec, 2020	UPLOAD
15 Dec, 2020	CORRESP

Last update:2024-03-06 12:51:18.462541

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.